Integra LifeSciences (NASDAQ:IART – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. Get Integra LifeSciences alerts:Check Out Our Latest Stock Report on IARTIntegra LifeSciences Stock Down 11.0%Shares of NASDAQ IART traded down $2.16 during trading on Wednesday, hitting $17.60. Integra LifeSciences has set its Q3 2026 guidance at 0.530-0.610 EPS and its FY 2026 guidance at 2.400-2.500 EPS. Integra LifeSciences News RoundupHere are the key news stories impacting Integra LifeSciences this week:Positive Sentiment: Second-quarter earnings exceeded expectations. Read MoreReceive News & Ratings for Integra LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.